We are a global medical technology company committed to providing peace of mind to patients and physicians alike through the use of MBI and PET as secondary screening and diagnostic tools.
The LumaGEM ® Molecular Breast Imaging (MBI) system has advanced photonics and image processing that provide images with a resolution as small as 1.6 mm. The high sensitivity and specificity of our products provide highly accurate imaging information that enable physicians to detect and treat breast cancer.
CMR Molecular Imaging is a unit of CMR Naviscan Corporation. We are headquartered in Carlsbad, California, and US FDA registered.
Brands: Naviscan Solo II PET Scanner
Stereo Navigator Biopsy Guidance Accessory
LumaGEM Molecular Breast Imaging (MBI)